1. Home
  2. SCPH vs VNME Comparison

SCPH vs VNME Comparison

Compare SCPH & VNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • VNME
  • Stock Information
  • Founded
  • SCPH 2013
  • VNME 2025
  • Country
  • SCPH United States
  • VNME United States
  • Employees
  • SCPH N/A
  • VNME N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • VNME Blank Checks
  • Sector
  • SCPH Health Care
  • VNME Finance
  • Exchange
  • SCPH Nasdaq
  • VNME Nasdaq
  • Market Cap
  • SCPH 299.0M
  • VNME 255.4M
  • IPO Year
  • SCPH 2017
  • VNME 2025
  • Fundamental
  • Price
  • SCPH $5.62
  • VNME $9.92
  • Analyst Decision
  • SCPH Buy
  • VNME
  • Analyst Count
  • SCPH 3
  • VNME 0
  • Target Price
  • SCPH $12.00
  • VNME N/A
  • AVG Volume (30 Days)
  • SCPH 2.4M
  • VNME 164.1K
  • Earning Date
  • SCPH 11-12-2025
  • VNME 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • VNME N/A
  • EPS Growth
  • SCPH N/A
  • VNME N/A
  • EPS
  • SCPH N/A
  • VNME N/A
  • Revenue
  • SCPH $49,969,000.00
  • VNME N/A
  • Revenue This Year
  • SCPH $108.95
  • VNME N/A
  • Revenue Next Year
  • SCPH $78.30
  • VNME N/A
  • P/E Ratio
  • SCPH N/A
  • VNME N/A
  • Revenue Growth
  • SCPH 107.79
  • VNME N/A
  • 52 Week Low
  • SCPH $1.94
  • VNME $9.89
  • 52 Week High
  • SCPH $6.28
  • VNME $9.95
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 52.96
  • VNME N/A
  • Support Level
  • SCPH N/A
  • VNME N/A
  • Resistance Level
  • SCPH $5.62
  • VNME N/A
  • Average True Range (ATR)
  • SCPH 0.04
  • VNME 0.00
  • MACD
  • SCPH -0.21
  • VNME 0.00
  • Stochastic Oscillator
  • SCPH 99.56
  • VNME 0.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About VNME Vendome Acquisition Corporation I Class A Ordinary Shares

Vendome Acquisition Corp I is a blank check company.

Share on Social Networks: